Hypophosphatemia

Last updated: February 23, 2023

Hypophosphatemia

GMED

GMED

Gastroesophageal reflux disease (GERD)
Gastroesophageal reflux disease (GERD): Clinical
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Asthma: Clinical
Asthma
Asthma: Information for patients and families (The Primary School)
Chronic kidney disease
Chronic kidney disease: Clinical
Anemia of chronic disease
Kidney stones
Acute kidney injury: Clinical
Anatomy of the abdominal viscera: Kidneys, ureters and suprarenal glands
Prerenal azotemia
Renal system anatomy and physiology
Renal azotemia
Postrenal azotemia
Renal failure: Pathology review
Taking a good patient history
Using an inhaler: Information for patients and families
Macrocytic anemia: Pathology review
Anemia: Clinical
Aplastic anemia
Extrinsic hemolytic normocytic anemia: Pathology review
Microcytic anemia: Pathology review
Autoimmune hemolytic anemia
Non-hemolytic normocytic anemia: Pathology review
Iron deficiency anemia
Intrinsic hemolytic normocytic anemia: Pathology review
Megaloblastic anemia
Obstructive lung diseases: Pathology review
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Cholinomimetics: Direct agonists
General anesthetics
Pulmonary corticosteroids and mast cell inhibitors
Isolated primary immunoglobulin M deficiency
Muscarinic antagonists
Cell-mediated immunity of CD4 cells
Adrenergic antagonists: Beta blockers
Non-steroidal anti-inflammatory drugs
Chronic obstructive pulmonary disease (COPD): Clinical
Clinical Skills: Using a metered-dose inhaler
Psychomotor stimulants
Tobacco use disorder
Cholinomimetics: Indirect agonists (anticholinesterases)
Sympathomimetics: Direct agonists
Jaundice
Neonatal jaundice: Clinical
Jaundice: Clinical
Jaundice: Pathology review
Cholestatic liver disease
Cirrhosis
Cirrhosis: Pathology review
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Cirrhosis: Clinical
Urinary tract infections: Clinical
Urinary incontinence
Urinary incontinence: Pathology review
Renal and urinary tract masses: Pathology review
Bladder exstrophy
Neurogenic bladder
Elimination disorders: Clinical
Cholinergic receptors
Inflammatory bowel disease: Pathology review
Inflammatory bowel disease: Clinical
Irritable bowel syndrome
Small bowel ischemia and infarction
Bowel obstruction: Clinical
Diarrhea: Clinical
Electrolyte disturbances: Pathology review
Laxatives and cathartics
Acetaminophen (Paracetamol)
Peptic ulcer
Peptic ulcers and stomach cancer: Clinical
Gastrointestinal bleeding: Pathology review
Ulcerative colitis
Liver histology
Alcohol-associated liver disease
Liver anatomy and physiology
Non-alcoholic fatty liver disease
Anatomy of the abdominal viscera: Liver, biliary ducts and gallbladder
Hepatic encephalopathy
Gastrointestinal system anatomy and physiology
Bowel obstruction
Enteric nervous system
Pulmonary hypertension
Pulmonary edema
Osteoarthritis
Rheumatoid arthritis and osteoarthritis: Pathology review
Joint pain: Clinical
Gout
Gout and pseudogout: Pathology review
Antigout medications
Glucocorticoids
Osmotic diuretics
Loop diuretics
Potassium sparing diuretics
Thiazide and thiazide-like diuretics
Diabetic nephropathy
Hyperkalemia: Clinical
Hypokalemia: Clinical
Metabolic and respiratory alkalosis: Clinical
Hyponatremia
Metabolic alkalosis
Hypernatremia: Clinical
Hypertension: Clinical
Hyperphosphatemia
Hypokalemia
Hyponatremia: Clinical
Hypernatremia
Hypermagnesemia
Hyperkalemia
Hypercalcemia
Portal hypertension
Rheumatoid arthritis: Clinical
Rheumatoid arthritis
Hypocalcemia
Hypoxia
Hypomagnesemia
Hypophosphatemia
Orthostatic hypotension

Transcript

Watch video only

Hypo- means under, phosphat- refers to phosphate, and -emia refers to the blood, so hypophosphatemia means having a low phosphate level in the blood, typically below 2.5mg/dL.

Phosphate is made up of one central phosphorus atom surrounded by four oxygen atoms in a tetrahedral arrangement, like a mini pyramid, and has a charge of minus 3 and is written PO43-.

In the body, about 85% of the phosphate is stored in the bones, where it combines with calcium to make a tough compound called hydroxyapatite which is the stuff that makes bones hard.

Of the remaining phosphate, a tiny amount is extracellular, or outside cells like in the blood, so this is the bit that gets measured, and the majority is intracellular, or inside cells, where it does all sorts of things.

It’s responsible for phosphorylation, where it binds to fats and proteins.

It forms the high energy bonds of adenosine triphosphate or ATP, which is the most common energy currency in the cell.

It’s part of the DNA and RNA backbone that links individual nucleotides together, and is also part of cellular signaling molecules like cyclic-adenosine monophosphate or cAMP.

Bottom line - phosphate is super important.

Because most of the phosphate is locked up with calcium in the bones, the levels of phosphate are heavily tied with the levels of ionized calcium in the body.

If calcium levels fall, the four parathyroid glands buried within the thyroid gland release parathyroid hormone which frees up both calcium and phosphate ions from the bones.

It does this by stimulating osteoclasts, the cells that break bone down, to release hydrogen ions which dissolves the hard, mineralized hydroxyapatite.

As soon as the positively-charged calcium and negatively-charged phosphate are released from the bones, they grab onto each other again like a pair of star-crossed lovers, meaning that the ionized calcium level doesn’t really go up very much at all.

Now, these two make their way to the nephron of the kidney, and at this point in the proximal convoluted tubule, phosphate usually gets reabsorbed back into the blood via sodium-phosphate cotransporters.

It turns out, though, that parathyroid hormone also shuts this down.

This means that phosphate is left in the lumen and eventually gets sent out in the urine.

Now, that calcium’s still in the lumen, though, but parathyroid hormone also affects the distal convoluted tubule and increases calcium reabsorption.

So when the dust settles, as a result of parathyroid hormone, phosphate is lost in the urine while ionized calcium is kept in the blood, so ionized calcium levels rise and phosphate levels fall!

With all of this in mind, hypophosphatemia can develop a few different ways.

The first possibility is by having excess losses of phosphate.

This can result in conditions like primary hyperparathyroidism which result in too much parathyroid hormone, which leads to excess phosphate being excreted in the urine.

Another example is Fanconi syndrome, which is where the proximal convoluted tubule essentially loses its capacity to reabsorb a variety of solutes - including phosphate - once again letting it get excreted in the urine.

Another possibility is not absorbing enough through the gastrointestinal tract, because usually phosphate ions are absorbed in the GI tract, but some substances like alcohol or a medication can impair that phosphate absorption, which means it gets excreted.

This includes antacids that contain aluminum, calcium, or magnesium, all of which are positive ions that can bind with the negatively charged phosphate and block absorption.

Alternatively, a person may simply not be getting enough phosphate in the diet, although this is unusual because it’s found in nearly all foods.